Argenx
ARGX
#516
Rank
โ‚น3.507 T
Marketcap
โ‚น57,719
Share price
1.88%
Change (1 day)
80.47%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Net assets

Net assets on the balance sheet as of June 2024 : โ‚น368.79 Billion

According to Argenx 's latest financial reports the company has โ‚น368.79 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Argenx - Net assets on balance sheet (from 2021 to 2020)

Net assets by year

Year Net assets Change
2022-12-31$โ‚น232.83 B23.44%
2021-12-31$โ‚น188.62 B25.26%
2020-12-31$โ‚น150.58 B59.7%
2019-12-31$โ‚น94.29 B91.41%
2018-12-31$โ‚น49.26 B55.39%
2017-12-31$โ‚น31.70 B565.46%
2016-12-31$โ‚น4.76 B60.87%
2015-12-31$โ‚น2.96 B-36.91%
2014-12-31$โ‚น4.69 B83.57%
2013-12-31$โ‚น2.55 B112.03%
2012-12-31$โ‚น1.20 B-37.08%
2011-12-31$โ‚น1.91 B214.25%
2010-12-31$โ‚น0.60 B